| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_988efab8d8e099a70f1c197c1bac4599 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M1-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-20 |
| filingDate |
2008-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2011-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_24ebf524aa78a72b8866a5f1a6fb2134
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_75bef14a3854b21ba0c0228223181e3d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a9f12c2694d41f3cf08ccf223dcc929
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9feeb60d20589c181f01b74395f98685
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fcf3e3f4a01b99810959dfb5943fa11b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_915c1767045411edc56bbde875227924
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_089d84aa2dcbb818f9e6f0406e15cd98
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7119369641d5bc55fbce6ede7290bbe9 |
| publicationDate |
2011-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-2408381-C2 |
| titleOfInvention |
Method of treating secondary lymphedema of upper extremities |
| abstract |
FIELD: medicine. n SUBSTANCE: invention refers to medicine, namely to surgery, and can be used in treating patients with secondary lymphedema of upper extremities. That is ensured by the introduction of autolymphocytes extracorporally processed with Roncoleukin and dissolved in normal saline in subcutaneous fat of an injured extremity in a projection of lymph node basins along a medial and lateral surface of forearm. The solution is introduced in 20 points by 0.5 ml containing 20 to 30 million cells per each point on the average. The procedures are thrice-repeated every 72 hours. n EFFECT: method allows to intensify lymphatic outflow from the injured extremity, to reduce paravasal inflammations of subcutaneous fat due to stimulating cell components of the immune system. n 8 tbl, 1 ex |
| priorityDate |
2008-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |